Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas is a research paper published in Laryngoscope Investigative Otolaryngology (2021). On theSindex it has a DataRank of 0. It has been cited 37 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA201382
National Cancer Institute
Grant: U01CA076576
U.S. Department of Defense
Grant: W81XWH‐14‐1‐0167
U.S. Department of Defense
Grant: W81XWH‐18‐1‐0547
NCI NIH HHS
Grant: P30 CA016058
NCI NIH HHS
Grant: T32 CA247815
NCI NIH HHS
Grant: UM1 CA186712
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
National Institutes of Health
Grant: 5R01CA201382-04
Overcoming IMiD resistance in Myeloma
National Institutes of Health
Grant: 5U01CA076576-05
PHASE I TRIALS OF ANTICANCER AGENTS
FWCI
2.49
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals